selegiline hydrochloride

Generic: selegiline hydrochloride

Labeler: marlex pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name selegiline hydrochloride
Generic Name selegiline hydrochloride
Labeler marlex pharmaceuticals, inc.
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

selegiline hydrochloride 5 mg/1

Manufacturer
Marlex Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 10135-737
Product ID 10135-737_441eef3c-3c0d-08b3-e063-6394a90afef9
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA075352
Listing Expiration 2026-12-31
Marketing Start 2021-05-01

Pharmacologic Class

Classes
monoamine oxidase inhibitor [epc] monoamine oxidase inhibitors [moa] monoamine oxidase type b inhibitor [epc] monoamine oxidase-b inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 10135737
Hyphenated Format 10135-737

Supplemental Identifiers

RxCUI
859186
UNII
6W731X367Q

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name selegiline hydrochloride (source: ndc)
Generic Name selegiline hydrochloride (source: ndc)
Application Number ANDA075352 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 5 mg/1
source: ndc
Packaging
  • 60 CAPSULE in 1 BOTTLE (10135-737-60)
source: ndc

Packages (1)

Ingredients (1)

selegiline hydrochloride (5 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "441eef3c-3c0d-08b3-e063-6394a90afef9", "openfda": {"unii": ["6W731X367Q"], "rxcui": ["859186"], "spl_set_id": ["df88d6bf-0fda-3825-e053-2a95a90a3a75"], "manufacturer_name": ["Marlex Pharmaceuticals, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "60 CAPSULE in 1 BOTTLE (10135-737-60)", "package_ndc": "10135-737-60", "marketing_start_date": "20210501"}], "brand_name": "Selegiline Hydrochloride", "product_id": "10135-737_441eef3c-3c0d-08b3-e063-6394a90afef9", "dosage_form": "CAPSULE", "pharm_class": ["Monoamine Oxidase Inhibitor [EPC]", "Monoamine Oxidase Inhibitors [MoA]", "Monoamine Oxidase Type B Inhibitor [EPC]", "Monoamine Oxidase-B Inhibitors [MoA]"], "product_ndc": "10135-737", "generic_name": "Selegiline Hydrochloride", "labeler_name": "Marlex Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Selegiline Hydrochloride", "active_ingredients": [{"name": "SELEGILINE HYDROCHLORIDE", "strength": "5 mg/1"}], "application_number": "ANDA075352", "marketing_category": "ANDA", "marketing_start_date": "20210501", "listing_expiration_date": "20261231"}